Physical Deconditioning
Conditions
Brief summary
This study investigates low-load, cuff-assisted training to improve mitochondrial capacity. The intervention is carried out using automated pressure cuffs, applying an individualized pressure of 70% of the limb occlusion pressure. This approach reflects the current scientific consensus for safe and effective use in clinical populations. Within a rehabilitation setting, two training modalities are compared: intermittent strength training and alternating continuous endurance training. Muscle oxygen saturation is measured non-invasively using near-infrared spectroscopy.
Interventions
Pre/Post comparison of mitochondrial capacity of the m. vastus lateralis muscle and muscle morphology between the groups.
Pre/Post comparison of mitochondrial capacity of the m. vastus lateralis muscle and muscle morphology between the groups
Pre/Post comparison of mitochondrial capacity of the m. vastus lateralis muscle and muscle morphology between the groups
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion: * Medically confirmed generalized deconditioning with reduced muscle strength * Medical certification of suitability for functional lower-extremity strength training * Written informed consent after an adequate reflection period Exclusion: * Unstable arrhythmias, myocardial ischemia, symptomatic blood pressure drops or hypertension (\>160/100 mmHg despite medication) * History of thrombosis or acute swelling/skin discoloration of the legs * Dizziness, confusion, cyanosis, or unexplained fatigue * Participant's wish to withdraw or not participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of changes in the mitochondrial capacity of skeletal muscle (of the thigh muscle, vastus lateralis; measured non-invasively) | From enrollment to the end of treatment at 6 weeks. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Minimum and maximum oxygen saturation (SmO₂) during application of pressure cuffs (measured via NIRS) | From enrollment to the end of treatment at 6 weeks. | — |
| Changes in total hemoglobin (tHb) as a measure of local blood volume (measured via NIRS) | From enrollment to the end of treatment at 6 weeks. | — |
| Assessment of subjective functional mobility using the "Lower Extremity Functional Scale" (LEFS) questionnaire | From enrollment to the end of treatment at 6 weeks. | Maximal Score: 80; Minimal Score: 0; Higher Score indicates better functional mobility |